Alexandria Real Estate Equities Inc (ARE)
Alexandria Real Estate Equities Inc (NYSE-ARE) is a health care REIT and NYSE-listed common stock. In this REIT context, the company’s business centers on owning, developing, and managing specialized real estate used by life science and research tenants. Its portfolio focus is on properties that support laboratories, innovation space, and other facilities tied to scientific and medical work. The security represents an equity interest in a real estate investment trust rather than an operating industrial or technology company. Investors typically view the stock through the lens of property operations, leasing, development activity, and the broader demand for specialized research-related real estate.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-ARE
|
$66.65
|
31.6% Upside
|
Undervalued
|
$51
|
0.7% Upside
|
Fair
|
Fair
|
—
|
—
|
2.88
|
5.8%
|
August 3, 2026
|
-8.2x
|
0.6x
|
3.0x
|
8.722 B
|
23.321 B
|
51.0%
|
88.7%
|
0.5
|
-76.0%
|
-131.4%
|